OraSure Technologies to Present at UBS Global Healthcare Conference
15 Maggio 2019 - 12:00PM
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of
care diagnostic tests and specimen collection devices, today
announced that Dr. Stephen S. Tang, President and CEO, will speak
to the investment community at the UBS Global Healthcare
Conference. The conference will be simultaneously webcast
over the Internet.
Dr. Tang is scheduled to speak on Wednesday, May
22, 2019, at approximately 9:30 AM Eastern Time (6:30 AM Pacific
Time). Interested investors can access the live webcast of
the presentation by going to OraSure Technologies’ web site,
www.orasure.com and clicking on the Investors link. A replay
of the webcast will be available on OraSure Technologies’ web site
for seven days. Alternatively, you can access the live
webcast of the presentation via the following link:
https://cc.talkpoint.com/ubsx001/052019a_as/?entity=27_HV8OTB2
About OraSure
TechnologiesOraSure Technologies is empowering the global
community to improve health and wellness by providing access to
accurate essential information. OraSure is a leader in the
development, manufacture and distribution of point-of-care
diagnostic tests, molecular collection devices and other
technologies designed to detect or diagnose critical medical
conditions. Its first-to-market, innovative products include rapid
tests for the detection of antibodies to HIV and Hepatitis C (HCV)
on the OraQuick® platform, sample self-collection and stabilization
products for molecular applications, and oral fluid laboratory
tests for detecting various drugs of abuse. Together with its
wholly-owned subsidiaries (DNA Genotek, CoreBiome and Novosanis),
OraSure provides its customers with value-added, end-to-end
solutions that encompass tools, diagnostics and services.
OraSure’s portfolio of products is sold globally to various
clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, research
institutions, distributors, government agencies, physicians’
offices, commercial and industrial entities and consumers. For more
information on OraSure Technologies, please visit
www.orasure.com.
Company contact:
Roberto Cuca |
Jeanne Mell |
Chief Financial Officer |
VP Corporate Communications |
610-882-1820 |
484-353-1575 |
Investorinfo@orasure.com |
media@orasure.com |
www.orasure.com |
www.orasure.com |
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Lug 2023 a Lug 2024